Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Identify smart fund options for retirement diversification, focusing on balance, risk management, and practical allocation ideas for real-world use.
24,189 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
Jack in the Box reported softer results in its latest quarter, bringing attention to jack box's revenue sales trends....
Bitcoin has quieted its swings, but risk-aware investors are still buying protection. This guide explains why hedges ...
After a steep slide, Novo Nordisk has shown fresh momentum. But can the rebound sustain, or is it just a temporary bo...
Target just gave investors a fresh reason to rethink risk and opportunity in retail. After a solid earnings beat and ...
A major defense buildup debate affects portfolios as lawmakers consider a 355-ship Navy. This article breaks down the...
Broadcom’s latest results point to strong AI-chip momentum even as the market reacts. This article breaks down what t...
If you are weighing where to invest in the chip sector, this article breaks down how Intel and TSMC differ, what that...
Dell Technologies grabbed headlines as its AI-focused strategy started to show momentum. This piece breaks down why d...
MRCC unveiled a $0.75 special distribution tied to reserve funds as it merges with HRZN. Despite the payout, investor...
As investors scan early 2026 results, worksport (WKSP) 2026 earnings reveal how a niche hardware maker navigates supp...